|
1
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cortez AJ, Tudrej P, Kujawa KA and
Lisowska KM: Advances in ovarian cancer therapy. Cancer Chemother
Pharmacol. 81:17–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Naumann RW, Coleman RL, Brown J and Moore
KN: Phase III trials in ovarian cancer: The evolving landscape of
front line therapy. Gynecol Oncol. 153:436–444. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paik ES, Shim M, Choi HJ, Lee YY, Kim TJ,
Lee JW, Kim BG, Bae DS and Choi CH: Impact of lymphadenectomy on
survival after recurrence in patients with advanced ovarian cancer
without suspected lymph node metastasis. Gynecol Oncol.
143:252–257. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worzfeld T, Pogge von Strandmann E, Huber
M, Adhikary T, Wagner U, Reinartz S and Müller R: The unique
molecular and cellular microenvironment of ovarian cancer. Front
Oncol. 7:242017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takeda T, Banno K, Okawa R, Yanokura M,
Iijima M, Irie-Kunitomi H, Nakamura K, Iida M, Adachi M, Umene K,
et al: ARID1A gene mutation in ovarian and endometrial cancers
(Review). Oncol Rep. 35:607–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Expósito-Villén A, E Aránega A and Franco
D: Functional role of non-coding RNAs during
epithelial-to-mesenchymal transition. Noncoding RNA.
4:E142018.PubMed/NCBI
|
|
13
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Wen J, Wang H and Wang Y: Long
non-coding RNA LINC00460 promotes epithelial ovarian cancer
progression by regulating microRNA-338-3p. Biomed Pharmacother.
108:1022–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Liu C, Lu Z, Chen L, Wang J, Li Y
and Ma H: Upregulation of the long non-coding RNA SPRY4-IT1
indicates a poor prognosis and promotes tumorigenesis in ovarian
cancer. Biomed Pharmacother. 88:529–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J and Liu Z: Long non-coding RNA
TTN-AS1 promotes the progression of lung adenocarcinoma by
regulating PTEN/PI3K/AKT signaling pathway. Biochem Biophys Res
Commun. 514:140–147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan Y, Li Y, Guan B, Chen X, Chen Z, He
A, He S, Gong Y, Peng D, Liu Y, et al: Increased expression of long
non-coding RNA CCEPR is associated with poor prognosis and promotes
tumorigenesis in urothelial bladder carcinoma. Oncotarget.
8:44326–44334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhan L, Li J and Wei B: Long non-coding
RNAs in ovarian cancer. J Exp Clin Cancer Res. 37:1202018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong Y, Gao D, He S, Shuai C and Peng S:
Dysregulated expression of long noncoding RNAs in ovarian cancer.
Int J Gynecol Cancer. 26:1564–1570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma N, Li S, Zhang Q, Wang H, Qin H and
Wang S: Long non-coding RNA GAS5 inhibits ovarian cancer cell
proliferation via the control of microRNA-21 and SPRY2 expression.
Exp Ther Med. 16:73–82. 2018.PubMed/NCBI
|
|
24
|
Liu Y, Wang Y, Fu X and Lu Z: Long
non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis
through regulation of miR-382-3p/ROCK1 axial. Cancer Sci.
109:2188–2198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Wang Y, Yao D and Cui D: LncSOX4
serves an oncogenic role in the tumorigenesis of epithelial ovarian
cancer by promoting cell proliferation and inhibiting apoptosis.
Mol Med Rep. 17:8282–8288. 2018.PubMed/NCBI
|
|
26
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu XY, Hou PF, Li TT, Quan HY, Li ML, Lin
T, Liu JJ, Bai J and Zheng JN: The roles of Wnt/β-catenin signaling
pathway related lncRNAs in cancer. Int J Biol Sci. 14:2003–2011.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng X, Xu X, Chen D, Zhao F and Wang W:
Therapeutic potential of targeting the Wnt/β-catenin signaling
pathway in colorectal cancer. Biomed Pharmacother. 110:473–481.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arend RC, Londono-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang L, Jin Y, Feng S, Zou Y, Xu S, Qiu
S, Li L and Zheng J: Role of Wnt/β-catenin, Wnt/c-Jun N-terminal
kinase and Wnt/Ca2+ pathways in cisplatin-induced
chemoresistance in ovarian cancer. Exp Ther Med. 12:3851–3858.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mei Y, Liu YB, Cao S, Tian ZW and Zhou HH:
RIF1 promotes tumor growth and cancer stem cell-like traits in
NSCLC by protein phosphatase 1-mediated activation of Wnt/β-catenin
signaling. Cell Death Dis. 9:9422018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zeng S, Seifert AM, Zhang JQ, Cavnar MJ,
Kim TS, Balachandran VP, Santamaria-Barria JA, Cohen NA, Beckman
MJ, Medina BD, et al: Wnt/β-catenin signaling contributes to tumor
malignancy and is targetable in gastrointestinal stromal tumor. Mol
Cancer Ther. 16:1954–1966. 2017. View Article : Google Scholar : PubMed/NCBI
|
